Noscendo

Noscendo operates as a diagnostics company.

Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections.

Number of Funding Rounds

Total Funding Amount

2

—

Noscendo has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 16, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 16, 2022	Series Unknown	—	1	—	—	Detail
Apr 23, 2020	Series A	—	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

1

Noscendo is funded by 1 investors. SquareOne are the most recent investors.

Investor Name	Lead Investor	Funding Round
SquareOne	—	Series Unknown